Lindsay A. JAMA Intern Med. 2019;179(11):1519-1527.
It’s a retrospective cohort study.
Antibiotic treatment of asymptomatic bacteriuria in hospitalized patients appears to be common, may not be associated with improved clinical outcomes, and may be associated with longer duration of hospitalization after urine testing.
To possibly reduce inappropriate antibiotic use, stewardship efforts should focus on improving urine testing practices and management strategies for elderly patients with altered mental status.
Our study identified new ...
Ganguli I. JAMA Intern Med. 2019;179(9):1211-1219.
It’s a cohor study.
Care cascades after preoperative EKG for cataract surgery are infrequent but costly. Policy and practice interventions to reduce low-value services and the cascades that follow could yield substantial savings.
Robust evidence, codified in multiple guidelines, makes clear that routine testing before this prevalent, low-risk, elective surgery does not improve outcomes or lower the risk of adverse events among Medicare beneficiaries.
As a result we coud see that beneficiaries ...
It’s a microsimulation modeling study of a hypothetical cohort.
The uniform CT imaging for patients with hematuria was associated with increased costs and harms of secondary cancers, procedural complications, and false positives, with only a marginal increase in cancer detection. Risk stratification may optimize the balance of advantages, harms, and costs of CT.
Asymptomatic microscopic hematuria, the focus of these analyzes, has a relatively low pretest probability for cancer. ...
Ruzicka M. JAMA Intern Med. 2019;179(10):1433-1434.
It’s a prospective observational cohort study.
The results suggest that nonadherence to BP-lowering drug regimens is high among referred patients with apparent treatment-resistant hypertension, even among those who said they were adherent on questioning before DOT, had pristine pharmacy filling records, and had accurate pill counts.
The apparent nonadherence occurred despite more than 50% of these patients already having had an adverse vascular event related to uncontrolled hypertension. ...
George F. Sawaya, MD.JAMA Intern Med. 2019;179(7):867-878.
The cross-sectional portion of this study enrolled a convenience sample of 451 women aged 21 to 65 years to estimate the cos-effectiveness of 12 cervical cancer screeining strategies.
Of 12 strategies evaluated in a cost-effectiveness model, cytologic testing every 3 years for women aged 21 to 29 years with either continued triennial cytologic testing or switching to a low-cost high-risk human papillomavirus test every 5 years from age 30 to 65 years conferred a reasonable balance of benefits, ...